Homologous Wasting Disease - 25 Studies Found
Completed |
: Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With Steroid Resistant Acute Graft Versus Host Disease : Graft Vs Host Disease : 2002-05-06 : Drug: ABX-CBL |
Completed |
: Safety and Efficacy Study of Photopheresis With UVADEX to Prevent Graft-versus-Host Disease : Graft-versus-Host Disease : 2003-02-05 :
|
Recruiting |
: A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory Chronic Graft-versus-Host-Disease : Chronic Graft-versus-host-disease : 2015-01-07 :
|
Terminated |
: A Randomized, Controlled, Double-Masked, Clinical Trial of Autologous Serum Eye Drops for Severe Ocular Chronic Graft-versus-Host Disease (GVHD) in Hematopoietic Stem Cell Transplant (HSCT) Patients : Graft vs Host Disease : 2013-10-23 :
|
Completed |
: Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease : Graft-versus-Host Disease : 2003-02-05 :
|
Recruiting |
: A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease : Graft vs Host Disease : 2015-03-01 : Biological: Donor regulatory T cell adoptive immunotherapy in chronic graft versus host disease |
Terminated |
: Alefacept for Prevention of Graft Versus Host Disease (GVHD) : Graft Versus Host Disease : 2006-07-31 :
|
Recruiting |
: A Phase I Study of Abatacept in the Treatment of Patients With Steroid Refractory Chronic Graft Versus Host Disease (cGVHD) : Chronic Graft Versus Host Disease : 2013-09-27 : Drug: Abatacept The study will follow a standard 3+3 design with two escalating doses of abatacept to de |
Recruiting |
: Mesenchymal Stem Cells as a Treatment for Oral Complications of Graft-versus-host Disease : Graft -Versus-host-disease : 2014-02-04 : Biological: Mesenchymal stromal cells Allogenous mesenchymal stromal cells will be injected directly und |
Completed |
: Rituximab for the Primary Treatment of Denovo Extensive Chronic Graft Versus Host Disease (GVHD) : Chronic Graft-versus-host Disease : 2010-07-12 : Drug: Rituximab Rituximab 375 mg/m2/dose x 4 weekly doses on days 1, 8, 15 and 22 and then at 3, 6, 9 an |